NORMOXYS

normoxys-logo

NormOxys, Inc. operates as a biopharmaceutical company. It provides proprietary products that regulate the binding affinity between oxygen and hemoglobin. NormOxys, Inc. was formerly known as Oxyplus, Inc. and changed its name to NormOxys, Inc. in October 2008. The company was founded in 2003.

#SimilarOrganizations #People #Financial #Website #More

NORMOXYS

Industry:
Biotechnology Health Care Medical

Founded:
2003-01-01

Address:
Wellesley, Massachusetts, United States

Country:
United States

Website Url:
http://www.normoxys.com

Total Employee:
11+

Status:
Active

Contact:
781-391-0770

Email Addresses:
[email protected]

Total Funding:
30.46 M USD

Technology used in webpage:
Google Analytics Apache Google Analytics Classic Unified Layer CentOS Apache 2.2 BlueHost


Similar Organizations

cel-sci-logo

CEL-SCI

CEL-SCI is a biotechnology company developing immunotherapy products for the treatment of cancer and other infectious diseases.

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

Current Employees Featured

not_available_image

Claude Nicolau
Claude Nicolau CSO, Founder @ NormOxys
CSO, Founder

not_available_image

Gerard Riedel
Gerard Riedel VP, regulatory affairs and program management @ NormOxys
VP, regulatory affairs and program management

Founder


not_available_image

Claude Nicolau

Investors List

index-ventures_image

Index Ventures

Index Ventures investment in Series B - NormOxys

care-capital_image

Care Capital

Care Capital investment in Series B - NormOxys

droia_image

Droia Ventures

Droia Ventures investment in Venture Round - NormOxys

Official Site Inspections

http://www.normoxys.com

Unable to get host informations!!!

Loading ...

More informations about "NormOxys"

NormOxys Inc. - LinkedIn

NormOxys Inc. | 106 followers on LinkedIn. Full company details available on the websiteSee details»

NormOxys - Tech Details - Crunchbase

NormOxys is a biotechnology company developing a new class of polyol phosphate-based small molecule drugs for the treatments of cancers.See details»

NormOxys 2025 Company Profile: Valuation, Funding â€Ļ

Information on valuation, funding, cap tables, investors, and executives for NormOxys. Use the PitchBook Platform to explore the full profile.See details»

NormOxys - News & Analysis - Crunchbase

Oct 23, 2013 NormOxys is a biotechnology company developing a new class of polyol phosphate-based small molecule drugs for the treatments of cancers.See details»

NormOxys - Financial Details - Crunchbase

NormOxys is a biotechnology company developing a new class of polyol phosphate-based small molecule drugs for the treatments of cancers.See details»

NormOxys - Products, Competitors, Financials, Employees, â€Ļ

NormOxys has discovered and is currently developing a proprietary technology platform that generates a class of small molecule drugs, oxyrens, which enhance the body's ability to â€ĻSee details»

NormOxys - VentureRadar

"NormOxys is a biopharmaceutical company headquartered in Boston, MA with laboratories in Boston and Strasbourg, France. NormOxys has discovered and is currently developing a novel â€ĻSee details»

NormOxys - Tech Stack, Apps, Patents & Trademarks - Crunchbase

NormOxys is a biotechnology company developing a new class of polyol phosphate-based small molecule drugs for the treatments of cancers.See details»

NormOxys - 2025 Company Profile, Funding & Competitors - Tracxn

Feb 24, 2025 NormOxys - Developing polyol phosphate-based small molecule drugs for the treatments of cancers. Raised a total funding of $24.2M over 5 rounds from 2 investors.See details»

NormOxys - Funding, Financials, Valuation & Investors

NormOxys is a biotechnology company developing a new class of polyol phosphate-based small molecule drugs for the treatments of cancers.See details»

Normoxys Inc. - BioCentury Company Profiles - BCIQ

Nov 15, 2022 Historical deals and financings can be found by searching the organization's name in the BCIQ Deals and Financing Modules.See details»

NormOxys, Inc. (NormOxys, Inc.) - č¯į‰ŠįŽĄįēŋ_专刊_临åēŠč¯•énj_æŠ•čžčĨ â€Ļ

May 7, 2025 NormOxys, Inc., is a small biotechnol. company that started the clin. phase of drug development in 2010. Based on fundamental research conducted over a thirty year period, â€ĻSee details»

NormOxys Inc - Company Profile and News - Bloomberg Markets

Company profile page for NormOxys Inc including stock price, company news, executives, board members, and contact informationSee details»

Normoxys, Inc. Company Profile | Medford, MA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for Normoxys, Inc. of Medford, MA. Get the latest business insights from Dun & Bradstreet.See details»

NormOxys company information, funding & investors | Dealroom.co

NormOxys, normoxys, inc | harnessing the advantages of a new class of small molecule drug derivatives of polyol phosphates for oncology treatment. Here you'll find information about their â€ĻSee details»

NormOxys - Overview, News & Similar companies | ZoomInfo.com

View NormOxys (www.normoxys.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and â€ĻSee details»

NormOxys - Contacts, Employees, Board Members, Advisors

NormOxys is a biotechnology company developing a new class of polyol phosphate-based small molecule drugs for the treatments of cancers.See details»

NormOxys Company Information - Funding, Investors, and More

Get information on funding, investors, industries, and more for NormOxys. See NormOxys company profile and funding data.See details»

NormOxys Appoints Industry Veteran and Recognized â€Ļ

Dec 4, 2009 "We are very pleased to appoint a recognized scientific expert and seasoned drug development executive to lead NormOxys, and Martin's decision to join our organization is a â€ĻSee details»

NormOxys - Crustdata Company Profile, Funding and Growth

NormOxys is a biotechnology company developing a new class of polyol phosphate-based small molecule drugs for the treatments of cancers.See details»

linkstock.net © 2022. All rights reserved